By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Versartis, Inc.  

4200 Bohannon Drive
Suite 250
Menlo Park  California  94025  U.S.A.
Phone: 650-963-8588 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Versartis (VSAR) Announces Three Year Somavaratan Data At ENDO 2017 Showing Safety And Efficacy In Line With Historical U.S. Daily rhGH Data In Pediatric GHD 4/3/2017 9:33:28 AM
Versartis (VSAR) Reports New Data On Long-Acting Somavaratan In Growth Hormone Deficiency At ENDO 2017 4/3/2017 7:42:56 AM
Versartis (VSAR) Presents Efficacy, Safety, Metabolic And Adherence Data For Somavaratan In Oral Session At The International Congress Of Endocrinology 9/6/2016 8:03:55 AM
Bay Area's Versartis (VSAR) Strikes $165 Million Growth Hormone Deal With Teijin Limited 8/10/2016 8:42:51 AM
Versartis, Inc. (VSAR) Presents Confirmatory 18-Month Adherence Data From Ongoing Somavaratan Extension Study At Late-Breaker Session At ENDO Annual Meeting 4/1/2016 8:04:15 AM
Versartis, Inc. (VSAR) To Present At The Cowen and Company 36th Annual Health Care Conference 3/2/2016 8:18:23 AM
Versartis, Inc. (VSAR) Reports Confirmatory Top-Line Two-Year Data From Ongoing Extension Study Of Somavaratan In GHD Children 2/2/2016 7:52:28 AM
Versartis, Inc. (VSAR) To Present At The Credit Suisse 24th Annual Healthcare Conference 11/4/2015 8:11:56 AM
Versartis, Inc. (VSAR) Reports Third Quarter 2015 Financial Results 10/30/2015 8:06:14 AM
Versartis, Inc. (VSAR) Presents Confirmatory 18-Month Data From Ongoing Somavaratan Extension Study At Late-Breaker Session At ESPE Annual Meeting 10/1/2015 7:59:31 AM
123456789
//-->